Skip to main content

July/August 2008, Vol 1, No 6

Bustling Pipeline for Diabetes and Its Metabolic Consequences
Wayne Kuznar
Read More
Editorial
Contracting for Compliance: Using Adherence as a Patient-Centered Measure of Performance
Scott R. Taylor, RPh, MBA, J. B. Jones, PhD, MBA, Nirav R. Shah, MD,MPH
Read More
Business
Wayward Prescriptions: Costs of Fraud in Payor Plans
Thomas Kaye, RPh, MBA, FASHP
Stakeholder Perspective
Procedures Needed to Prevent Prescription Fraud
by Susan Sarnoff, DSW
Read More
Bustling Pipeline for Diabetes and Its Metabolic Consequences
Wayne Kuznar
Read More
Industry Trends
FDA Bolsters Its Generic Approval Process: Health Plans Reap the Benefits
Read More
FDA Approvals
Heparin at the Center of the Storm
Mark Senak, JD
Read More
Clinical
Prescribing Warfarin Appropriately to Meet Patient Safety Goals
Lekshmi Dharmarajan, MD, FACP, FACC, T. S. Dharmarajan, MD, FACP, AGSF
Stakeholder Perspective
Benefits of Genetic Testing in Warfarin Therapy
by Teresa DeLuca, MD, MBA
Read More
Regulatory
Treading Water: The No-Growth Investment in Health Services Research
Emily J. Holubowich, MPP, Joseph R. Antos, PhD
Stakeholder Perspective
The Golden Age of Health Services Research
by Joseph R. Antos, PhD
Read More
Conference Highlights ISPOR
The International Society for Pharmacoeconomics and Outcomes Research: Implications for Decision Makers in Healthcare
Gordon M. Cummins, MS
Read More
Conference Highlights ISPOR
Select Topics from ISPOR, May 2008
Read More

Results 1 - 10 of 10